# Virological characteristics of the SARS-CoV-2 JN.1 variant

The supplemental tables for the GISAID datasets used in the following studies.

Yu Kaku*, Kaho Okumura*, Miguel Padilla-Branco, Yusuke Kosugi, Keiya Uriu, Alfredo A. Hinay Jr., Luo Chen, Arnon Plianchaisuk, Kouji Kobiyama, Ken J. Ishii, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jiri Zahradnik, Jumpei Ito, and Kei Sato. 2024. Virological characteristics of the SARS-CoV-2 JN.1 variant. *Lancet Infectious Diseases*. 24: e82. doi: 10.1016/S1473-3099(23)00813-7

Yu Kaku*, Kaho Okumura*, Miguel Padilla-Branco, Yusuke Kosugi, Keiya Uriu, Alfredo A. Hinay Jr., Luo Chen, Arnon Plianchaisuk, Kouji Kobiyama, Ken J. Ishii, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jiri Zahradnik, Jumpei Ito, and Kei Sato. 2023. Virological characteristics of the SARS-CoV-2 JN.1 variant. *bioRxiv*. doi: 10.1101/2023.12.08.570782

The EPI_SET_231130we dataset includes 72,503 genomic sequences of SARS-CoV-2 used in mutation frequency calculation (Figure S1A).\
The EPI_SET_231130yx dataset includes 61,086 genomic sequences of SARS-CoV-2 used in epidemic dynamics modeling analysis (Figures S1B and S1C).
